JP2021518393A5 - - Google Patents
Info
- Publication number
- JP2021518393A5 JP2021518393A5 JP2020550650A JP2020550650A JP2021518393A5 JP 2021518393 A5 JP2021518393 A5 JP 2021518393A5 JP 2020550650 A JP2020550650 A JP 2020550650A JP 2020550650 A JP2020550650 A JP 2020550650A JP 2021518393 A5 JP2021518393 A5 JP 2021518393A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- antibody
- seq
- concentration
- amino acid
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647341P | 2018-03-23 | 2018-03-23 | |
| US62/647,341 | 2018-03-23 | ||
| PCT/US2019/023528 WO2019183448A1 (en) | 2018-03-23 | 2019-03-22 | Treatment and prophylaxis of amyloidosis |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021518393A JP2021518393A (ja) | 2021-08-02 |
| JPWO2019183448A5 JPWO2019183448A5 (https=) | 2022-03-29 |
| JP2021518393A5 true JP2021518393A5 (https=) | 2022-03-29 |
| JP7217287B2 JP7217287B2 (ja) | 2023-02-02 |
Family
ID=66041747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550650A Active JP7217287B2 (ja) | 2018-03-23 | 2019-03-22 | アミロイド症の処置および予防 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210017278A1 (https=) |
| EP (1) | EP3768311A1 (https=) |
| JP (1) | JP7217287B2 (https=) |
| KR (1) | KR20200143400A (https=) |
| CN (1) | CN112040983A (https=) |
| AU (2) | AU2019240413A1 (https=) |
| BR (1) | BR112020019172A2 (https=) |
| CA (1) | CA3095100A1 (https=) |
| EA (1) | EA202092264A1 (https=) |
| MX (1) | MX2020009920A (https=) |
| MY (1) | MY203432A (https=) |
| SG (1) | SG11202009295YA (https=) |
| WO (1) | WO2019183448A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2237803T3 (en) * | 2007-12-28 | 2015-10-05 | Prothena Biosciences Ltd | Treatment and prophylaxis of amyloidosis |
| SG10201604104PA (en) * | 2011-10-25 | 2016-07-28 | Prothena Therapeutics Ltd | Antibody formulations and methods |
| WO2018005967A1 (en) * | 2016-06-30 | 2018-01-04 | Prothena Therapeutics Limited | Compositions for treating amyloidosis |
-
2019
- 2019-03-22 MX MX2020009920A patent/MX2020009920A/es unknown
- 2019-03-22 KR KR1020207030523A patent/KR20200143400A/ko not_active Ceased
- 2019-03-22 WO PCT/US2019/023528 patent/WO2019183448A1/en not_active Ceased
- 2019-03-22 AU AU2019240413A patent/AU2019240413A1/en not_active Abandoned
- 2019-03-22 CA CA3095100A patent/CA3095100A1/en active Pending
- 2019-03-22 MY MYPI2020004912A patent/MY203432A/en unknown
- 2019-03-22 EP EP19715723.3A patent/EP3768311A1/en active Pending
- 2019-03-22 CN CN201980028739.4A patent/CN112040983A/zh active Pending
- 2019-03-22 BR BR112020019172-8A patent/BR112020019172A2/pt not_active Application Discontinuation
- 2019-03-22 US US17/040,343 patent/US20210017278A1/en not_active Abandoned
- 2019-03-22 JP JP2020550650A patent/JP7217287B2/ja active Active
- 2019-03-22 EA EA202092264A patent/EA202092264A1/ru unknown
- 2019-03-22 SG SG11202009295YA patent/SG11202009295YA/en unknown
-
2023
- 2023-04-05 AU AU2023202109A patent/AU2023202109A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7352973B2 (ja) | 二重特異性抗体及びその使用 | |
| JP2025037879A (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| JP7621939B2 (ja) | ＲＧＭｃ選択的阻害剤およびその使用 | |
| JP2021526534A5 (https=) | ||
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| JP2018529635A5 (https=) | ||
| RU2015144105A (ru) | Антитела к гепсидину и их применения | |
| RU2016137110A (ru) | Антитела к компоненту комплемента с5 | |
| CN110799543A (zh) | 肝细胞癌的免疫治疗 | |
| JP2010528607A (ja) | スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合性タンパク質 | |
| RU2018100824A (ru) | Антитела, которые связываются с сортилином и подавляют связывание програнулина | |
| CN110087683A (zh) | 稳定水性抗c5抗体组合物 | |
| JP2021511387A5 (https=) | ||
| JP2019519584A5 (https=) | ||
| RU2019140933A (ru) | Средства, пути применения и способы лечения | |
| JP2020533965A5 (https=) | ||
| JP2020527152A5 (https=) | ||
| WO2019076277A1 (zh) | 抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途 | |
| JP2022500382A5 (https=) | ||
| JP2020505350A5 (https=) | ||
| CN115957321A (zh) | 一种抗her2抗体在制备治疗癌症的药物中的用途 | |
| JPWO2020108611A5 (https=) | ||
| TW202321303A (zh) | 抗pla2r自體抗體媒介膜性腎病變之治療 | |
| JP2021518393A5 (https=) | ||
| IL319999A (en) | Bispecific antibodies against CD3 and CD20 - for the treatment of Richter syndrome |